Costs outpaced revenue, sending Valiant Organics profit down 41%
Revenue grew +31.39% sequentially, but a 5.15-point margin squeeze and lower other income cut net profit by -40.87%.
Filed 05 Nov 2026, 19:43 IST · after market close · Valiant Organics Ltd (VALIANTORG)
Key takeaways
- Revenue rose +31.39% sequentially, but expenses grew +39.64%, pulling operating margin down 5.15 percentage points to 12.83%.
- Net profit fell -40.87% sequentially as other income dropped -88.11% and the tax rate rose 9.77 percentage points.
- Operating margin was 0.31 percentage points below the 13.14% median for 123 reported Commodities peers.
Price around the results
Revenue growth did not translate into operating profit
Valiant Organics reported consolidated revenue of Rs 304.22 cr in Q2FY27, up +31.39% sequentially, but operating profit fell -6.25% to Rs 39.02 cr. Expenses increased +39.64%, faster than revenue, which reduced operating margin to 12.83% from 17.98% in Q1FY27. The company filed the results after market close on 05 Nov 2026.
Lower other income and a higher tax rate amplified the profit decline
Profit before tax fell -32.63% sequentially as other income dropped -88.11% to Rs 1.25 cr; other income represented 5.04% of pre-tax profit in the quarter. The tax rate rose 9.77 percentage points to 30.21%, despite tax expense being broadly unchanged sequentially, further widening the decline in net profit to -40.87%.
Margin was slightly below the reported peer median
The 12.83% operating margin was 0.31 percentage points below the 13.14% median among 123 Commodities peers that had reported the same quarter. With only Q1FY27 in the supplied quarterly trend, the clear direction is a sequential margin decline of 5.15 percentage points rather than a multi-quarter pattern.
Management flags import dependence in specialty chemicals
The company's investor presentation said its specialty chemicals have high demand but low supply and are primarily dependent on imports. That commentary frames the business opportunity, while the quarter's cost growth indicates that revenue expansion did not prevent operating-cost pressure.
Q2FY27 at a glance
Consolidated figures as filed with NSE — filed ahead of third-party databases, not yet independently cross-checked.
| Line item | Q2FY27 | Q1FY27 | QoQ |
|---|---|---|---|
| Revenue | ₹304 cr | ₹232 cr | +31.39% |
| Other income | ₹1 cr | ₹11 cr | -88.11% |
| Expenses | ₹265 cr | ₹190 cr | +39.64% |
| Operating profit | ₹39 cr | ₹42 cr | -6.25% |
| Operating margin (%) | 12.83% | 17.98% | — |
| Interest | ₹5 cr | ₹5 cr | +0.97% |
| Depreciation | ₹10 cr | ₹10 cr | +0.88% |
| Profit before tax | ₹25 cr | ₹37 cr | -32.63% |
| Tax | ₹7 cr | ₹8 cr | -0.40% |
| Net profit | ₹17 cr | ₹29 cr | -40.87% |
| EPS (₹) | ₹6.18 | ₹10.44 | -40.80% |
Operating margin of 12.83% compares with a Commodities sector median of 13.14% across 123 peers that have reported Q2FY27.
What management said
From the company’s own investor presentation. Each point is checked against the source document before it appears here.
Problems & risks
- The company says its specialty chemicals have high demand but low supply and are primarily dependent on imports.
What to watch
- Whether operating margin recovers from 12.83% after the 5.15-percentage-point sequential decline.
- Whether expense growth moderates from +39.64% relative to revenue growth of +31.39%.
- Whether other income remains close to 5.04% of pre-tax profit rather than the Q1FY27 level of Rs 10.51 cr.